These agents include thiazolidinediones (PPAR- agonists), dipeptidyl peptidase-4 (DPP-4) inhibitors, sulfonylureas, sodium-glucose co-transporter 2 (SGLT2) inhibitors, -glucosidase inhibitors, and glucagon-like peptide-1 (GLP-1) receptor agonists
By using upcyte LSECs, frequently observed problems such as rapid de-differentiation and low proliferation capacity in primary human LSECs 70 were circumvented without compromising on functionality and morphology
High homocysteine levels can lead to fatigue and weakness
Glutathione Tablets vs Glutathione Injections: Weight Gain Comparison Many people wonder whether the form of glutathione affects weight
(2021) 54(7):154360.e6
Consequently, governments, payers, and employers are beginning to adopt these agents as core components of preventive and chronic disease management strategies, driving exponential market demand